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CHARACTERIZATION OF THE INNATE RESPONSE TO THE RAGB PROTEIN 








More than 64 million people in the US suffer from some form of periodontal 
disease.  Periodontal diseases are bacterial infections of the hard and soft tissues 
surrounding the teeth which can lead to tooth loss.  Periodontal tissue destruction is 
caused by inflammatory host-pathogen interactions.  Porphyromonas gingivalis is a 
major causative agent of periodontal diseases and is a keystone periodontal pathogen.  
The 55kDa immunodominant RagB outer membrane protein of P. gingivalis has been 
proposed to facilitate iron transport.  However, potential interactions between RagB and 
the innate response have not been examined.  RagB homologues in gut Bacteroidetes 
have been associated with inflammatory bowel disease.  Therefore, we hypothesized that 
RagB aids in virulence of P. gingivalis and elicits a pro-inflammatory host response in 
innate cells.   
We determined that RagB exposure led to the differential and dose-related 
expression of multiple genes encoding pro-inflammatory mediators (IL-1β, IL-6, IL-8, 
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and CCL2) in primary human monocytes and to the secretion of TNF, IL-6 and 
IL-8.  RagB was shown to be a TLR2 and TLR4 agonist that activated STAT4 and NFκB 
transcription factors.  ∆ragB mutants also induced a reduced inflammatory response 
compared to the wild type strain as well as reduced survivability when exposed to oral 
epithelial cells which adds evidence to the role of ragB in epithelial cell colonization.  
These results suggest that ragB elicits a major pro-inflammatory response in primary 
human monocytes and therefore could play an important role in the etiology of 
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CHAPTER ONE:  INTRODUCTION 
 
Chronic Inflammatory Diseases 
The innate immune response must be tightly regulated and able to distinguish 
between foreign and domestic antigens.  Pathogens elicit innate responses but when the 
pathogen has been cleared the response must be turned off to prevent host cell and tissue 
destruction.  The central nervous system (CNS) regulates a feedback loop that optimizes 
innate inflammatory responses.  Glucocorticoids are anti-inflammatory molecules that are 
released to terminate inflammation. The NFκB pathway can be shut off by the interaction 
of RelA (p65) with glucorticoids, which induce IkB and stop the production of pro-
inflammatory cytokines [1].  If the response is left unchecked, then this can lead to the 
disruption of homeostasis and result in autoimmune diseases, cancers, septic shock and 
multiple chronic inflammatory diseases [2].    
According to the CDC, 7 out of 10 people in the US die of a chronic disease.  
Chronic inflammatory diseases are defined as long term inflammatory processes that are 
directed at particular endogenous or exogenous stimuli.  Pathogens that are able to persist 
and avoid being destroyed by the host can lead to the progression of chronic 
inflammation.  Diet and lifestyle also play a major role in chronic inflammatory diseases 
[3].  Obesity, which affects more than one third of adults in the US, is a risk factor for 
chronic inflammatory disease.  With the increase in fat cells, the output of inflammatory 
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molecules is increased and this can result in insulin resistance leading to diabetes 
and other diseases [4].   
Chronic inflammation leads to many chronic diseases including inflammatory 
bowel disease (IBD), periodontitis, type I diabetes, stroke, and many other chronic 
conditions.  There are many studies investigating strategies to control and down regulate 
inflammatory responses.  A major target for anti-inflammatory therapeutic treatment is 
the transcription regulator, NFκB.  NFκB plays a central role in inflammatory processes 
and numerous papers have shown NFκB to be a potential therapeutic agent for chronic 
inflammation [5-7].  For example, resveratrol, a natural polyphenol associated with anti-
inflammatory effects, has been shown to inhibit the progression of Alzheimer’s disease 
by interfering with TLR4/NFκB/STAT pathways [8].  Other transcriptional pathways are 
being investigated to be used for anti-inflammatory therapies.  Signal transducer and 
activator of transcription 4 (STAT4) is a major inflammatory mediator.  STAT4 has been 
shown to be necessary in the differentiation of B cells [9] and regulatory T cells [10].  
STAT4 plays a significant role in autoimmune diseases such as rheumatoid arthritis [11], 
inflammatory bowel disease [12], and type I diabetes [13].   STAT4 is a target of 
lisofylline (LSF) for anti-diabetic effects [14] which has been shown to inhibit STAT4 
activation through IL-12 signaling.  Lisofylline has also been shown to be useful in the 






               Chronic periodontitis, characterized by the destruction of the hard and soft 
tissues surrounding the teeth, is predominantly caused by the immune response to 
pathogenic bacteria present in the dental plaque.  Periodontitis and gingivitis are 
periodontal diseases that contribute to a major economic burden worldwide.  According 
to the World Health Organization, >60% of the population aged 35-44 years of age in the 
Americas have some form of periodontitis [16].   Gingivitis is a periodontal disease that 
is characterized by inflammation around the teeth, and if left untreated can lead to 
periodontitis.  The economic burden of periodontal diseases in the US is more than $14 
billion per annum [17].  More than 50% of the population in the US will have some form 
of periodontal disease in their lifetime [18].  People over the age of 60 have a greater than 
65% chance of having periodontitis.  More than 64 million people in the US have some 
form of periodontitis [19].   
There are many risk factors that contribute to periodontal diseases.  Poor oral 
hygiene, immunodeficiency, age, diabetes [20] and smoking [21] are all factors that can 
increase susceptibility to periodontal diseases [22, 23].  Smoking is a major risk factor for 
multiple diseases, in part, due to the massive number of carcinogens and toxins found in 
tobacco and tobacco smoke.  Smoking is the greatest environmental risk factor for 
periodontal diseases.  Smokers display a more severe form of periodontitis and are more 
refractory to treatment than non-smokers [24, 25].  Smoking also leads to a pathogen-
enriched oral microbiota [26]. 
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Tissue destruction is caused by a combination of bacterial insult and the host 
immune response to dental plaque.  Host cells release cytokines, proteases, and other 
factors which both combat pathogens and destroy tissue and host cells.  Bacteria, on the 
other hand, utilize an array of factors, such as the release of enzymes and toxins to 
increase their survivability in the host, some of which can cause host tissue destruction.   
The microbiome of healthy individuals consists of mainly aerobic Gram-positive 
bacteria, with a shift towards anaerobic Gram-negative bacteria noted in the diseased 
state [27].  Bacteria are able to colonize the junction between the tooth and oral 
epithelium and form biofilms, which make up dental plaque and lead to dental caries.  
Dental plaque consists of bacterial communities that lead to the destruction of enamel on 
the tooth by the release of metabolites produced from the breakdown of sugars by the 
bacteria.  Once the enamel is destroyed, dentin is exposed and bone destruction occurs 
more rapidly.  Bacterial biofilms protect the bacteria from host responses and allow 
bacteria to persist and further colonize the host.  Biofilms contain specific niches that 
allow for a diversity of bacteria to survive.  These environments provide nutrient 
gradients, various pH levels, and aerobic-anaerobic environments.  Biofilms also protect 
from phagocytosis and antibiotics [28, 29].   
Periodontal diseases are a risk factor for an array of diseases such as stroke [30, 
31], pulmonary diseases [32, 33], rheumatoid arthritis [34], and pre-term birth [35-37].  
Traditionally, the major causative agents of periodontal diseases were the “red complex” 
which included Tannerella forsythia, Treponema denticola and Porphyromonas 
gingivalis [38].  This concept has been recently superseded by the “keystone pathogen” 
hypothesis.  Keystone pathogens are those of relatively low number within the 
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microbiome which cause a disruption in the symbiosis of the normal flora leading to a 
more pathogenic state [39].  P. gingivalis has evolved strategies to impair the innate 
immunity by altering the entire biofilm and disrupting homeostatic host-microbial 
interactions in the periodontium [39, 40].  
Porphyromonas gingivalis   
Porphyromonas gingivalis, a Gram-negative, assaccharolytic anaerobe, is a 
causative agent of chronic periodontitis and a keystone pathogen of the sub-gingival 
biofilm [41].  P. gingivalis has also been associated with other diseases such as diabetes 
[20], rheumatoid arthritis [34], and other chronic inflammatory diseases [42].  
P. gingivalis employs many factors in its colonization of the oral cavity including 
the secretion of proteinase enzymes called gingipains that are capable of degrading host 
cell receptors, complement proteins, and other host components [43].  P. gingivalis is also 
very efficient in forming biofilms.  Biofilms play a major role in the colonization of the 
oral cavity allowing bacteria to form specialized niches.  Anaerobes are protected from 
oxygen rich environments by aerobic bacteria that are found on the outer layers of the 
biofilm.  Biofilms also protect bacteria against antibiotics and against phagocytosis by 
host immune cells.  Dental plaque is a bacterial biofilm that forms on the surface of the 
tooth and epithelium aiding the oral pathogens in disease progression. 
Because P. gingivalis is assaccharolytic, it is unable to break down carbohydrates 
for energy, therefore, it needs to acquire nutrients from the environment [44].  P. 
gingivalis is able to obtain amino acids from the subgingival environment due to 
secretion of proteases, along with other oral bacterial and host-derived proteases. The 
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destruction of connective tissue caused by the inflammatory response leads to a release of 
nutrients necessary for survival of P. gingivalis.  Thus, the immune response 
involuntarily aids P. gingivalis survival by providing essential nutrients that would not 
normally be available.    
 
Virulence Factors of Porphyromonas gingivalis  
P. gingivalis has an arsenal of virulence factors which aid in its ability to 
colonize, establish infection and cause disease.  These factors include capsule production, 
secretion of gingipains, LPS, fimbrial proteins and the rag locus [45].  
Capsule: To avoid phagocytosis, some P. gingivalis strains produce a negatively charged 
polysaccharide capsule.  There are six capsule serotypes (K1-K6) found in P. gingivalis 
[46].  The W83 strain used in this study contains the K1 serotype.   The extracellular 
capsule aids the bacteria in the resistance to being engulfed by neutrophils and other 
phagocytes of the immune system [47, 48].  A recent study showed a non-encapsulated 
mutant to be significantly more invasive than the wild type strain in human gingival 
fibroblasts, allowing it to avoid being killed by antibiotics [49].  Studies have also shown 
variations between serotypes of encapsulated strains differentially regulate the host 
immune response.  Encapsulated strains had a higher virulence in a mouse abscess model 
when compared to non-encapsulated strains [48, 50].  Thus, expression of the 
polysaccharide capsule may be beneficial for survival within the host both upregulated 
and downregulated.   
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Gingipains:  P. gingivalis produces three cysteine proteases called gingipains.  The 
gingipains include: RgpA and RgpB which are arginine-specific, and Kgp which is lysine 
specific [51, 52].  Gingipains are considered housekeeping proteases of P. gingivalis 
since they are able to degrade proteins into peptides which can then be used for growth 
and metabolism [43].  Gingipains utilize free amino acids as a source of carbon and 
nitrogen [53].  Gingipains are a major virulence factor that aids in attachment and 
colonization, evasion of host defenses, and tissue invasion and dissemination.  A recent 
study comparing wild type with a gingipain deficient mutant has showed gingpains play 
an important role in intracellular survival [54].  Gingipains are also able to degrade 
multiple complement components and host cell receptors to subvert the immune response 
[55, 56].   
LPS: P. gingivalis is atypical in that it is structurally different from typical 
enterobacterial LPS such as that found in E. coli.   P. gingivalis LPS contains lipid A 
heterogeneity containing tetra-(LPS1435/1449) and penta-(LPS1690) acylated forms [57, 58].  
P. gingivalis LPS has been shown to differentially activate TLR4-mediated NFκB which 
modulates expression of IL-6 and IL-8 in human gingival fibrobasts [59].  P. gingivalis 
LPS can signal inflammatory cytokines through both TLR2 and -4 [58, 59].  The 
LPS1435/1449 tetra form has been shown to weakly activate the immune response, while the 
LPS1690 penta form induces a much stronger inflammatory response [60].  Altering its 
lipid A structure contributes to P. gingivalis’ ability to evade the innate host’s defenses.   
Fimbrial proteins: Fimbriae are fine, numerous appendices that protrude from the outer 
cell membrane.  P. gingivalis produces several fimbrial proteins, including the major 
fimbrial antigen (FimA) and minor fimbrial antigen (Mfa1).  Mfa1, 67 kDa protein, are 
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shorter filaments (18-120nm) [61] and FimA,41kDa protein, are longer filaments (0.5-1 
µm) [62].  Both are considered virulence factors that aid in adherence and invasion of 
tissue [62, 63].  A recent study which used an in vitro biofilm model, showed fimbrial 
proteins aid P. gingivalis in binding to a primary oral colonizer, Streptococcus gordonii 
[64].  Both types of fimbriae stimulate pro-inflammatory cytokines though distinct TLR2 
pathways [65, 66].  Mfa1 has been shown to target C-type lectin receptors for invasion in 
monocyte-derived cells [67].  Our lab has shown FimA abrogates the pro-inflammatory 
response to TLR2 stimulation by other TLR2 specific agonists.  We have also shown a 
differential expression of fimbrial proteins in response to the environmental stress of 
tobacco smoke [65].   
rag locus  
The rag locus of P. gingivalis is comprised of receptor antigen A (ragA, PG0185), 
encoding a 115 kDa TonB-dependent receptor, and ragB (PG0186), encoding a 55 kDa 
putative lipoprotein (Figure 1) [68].  The rag proteins are homologous to the starch 
utilization system proteins, SusC and SusD, respectively, of gut Bacteroidetes [69]. The 
rag genes are co-transcribed, flanked by insertion sequences, and consist of a lower G+C 
ratio than the rest of the genome, suggesting the rag locus is a pathogenicity island that 
arose from horizontal transfer [68, 70].   
The exact function of the rag locus has yet to be determined.  RagA spans the 
outer membrane forming a beta-barrel like structure and is believed to be linked to a 
TonB-like protein, whereas RagB is exposed on the outer surface of the membrane in a 
complex with RagA [68].  The closest homolog is the Sus system that is involved in the 
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transportation and utilization of starch and other complex molecules [70], but it is still 
unclear of the role the rag locus plays in nutrient acquisition.  It has been hypothesized 
that the rag locus aids iron acquisition since it is analogous to transferrin binding systems 
found in Neisseria and Haemophilus species which contain a TonB-linked outer 
membrane protein (i.e. ragA) that is cotranscribed with a outermembrane lipoprotein (i.e. 
ragB) [68]. 
While host-RagB interactions are poorly understood, a recent study using P. 
gingivalis cell lysate and serum from patients with periodontitis has shown that RagB is 
the most immunodominant P. gingivalis antigen, and is clearly recognized by the immune 
system [71].  Recent data suggest that the rag operon may be essential for survival in 




Figure 1.  rag locus.  A schematic diagram of the rag locus and flanking genes in P. 
gingivalis [68].  The rag locus consists of ragA and ragB genes which are flanked by an 
insertion sequence (IS1126).  ragA contains a TonB box site and ragB contains a motif 





RagB is frequently found in P. gingivalis from periradicular lesions, [73] and is 
mostly commonly found in the strains isolated by deeper pocket depths using PCR 
analysis of subgingival plaque samples from periodontal patients and healthy control 
individuals[68]. This association suggests that rag aids the bacterium in establishing a 
more severe form of disease due to being found more frequently in deep pockets. rag 
mutants have been shown to be less virulent in a dorsal subcutaneous mouse model [74, 
75].  Ulcer sizes were significantly smaller in mice infected with rag mutants with very 
few bacteria recovered from the spleen, compared to the wild type [74].  Another group 
demonstrated rag knockout mutants inoculated by a dorsal subcutaneous infection had a 
significantly higher survival rate when compared to the wild type strain [75].  This 
suggests the rag locus could be a major virulence factor in vivo.   
RagB is under investigation as a potential periodontitis vaccine.  Zheng et.al used 
eukaryotic expression vector (pIRES) gene-linked to ragB as a DNA vaccine and showed 
mice inoculated intramuscularly with a ragB-linked DNA vaccine produced a strong anti-
RagB antibody response, were strongly resistant to P. gingivalis infection and displayed a 
significant reduction in lesion size compared to the control group [76].  RagB is also 
considered to play a essential role in the invasion of KB (HeLa-derived continuous cell 
line) cells based on genomic comparison of invasive and non-invasive strains using 





Innate Immune Response  
Humans are constantly exposed to microbes that have the ability to cause 
infection and disease.  The immune system has evolved to recognize and respond to the 
invading microbes, and to establish long term memory for certain pathogens.  The two 
main arms of the immune system are innate immunity and adaptive immunity, which 
work in concert to eliminate potential pathogens. 
The adaptive immune response involves immune memory and is highly specific 
for particular pathogen-derived antigens.  The innate immune response, on the other 
hand, relies on its ability to recognize common molecules of invading microbes.  Pattern 
recognition receptors (PRRs) on host cells recognize highly conserved microbe-
associated molecular patterns (MAMPs) [78]. Toll-like receptors (TLRs), C-type lectin 
receptors (CLRs), nucleotide-binding and oligomerization domain (NOD)-like receptors 
(NLRs) and retinoic acid-inducible gene I-like receptors (RIGs) are all PRRs that are 
expressed to recognize potential pathogens [79-81].  RIGs, NLRs and some TLRs are 
intracellular receptors while CLRs and other TLRs are membrane bound surface exposed 
receptors [82, 83].   
Humans express ten known TLRs in epithelial, endothelial and leukocyte 
subtypes.   Some TLRs can form complexes with other TLRs such as TLR2, which is 
capable of forming heterodimers with both TLR1 and -6.  Agonists of TLRs include 
triacyl lipopeptides, dsDNA, LPS, flagellin, diacyl lipopeptides, imidazoquinoline 
amines, ssRNA, and unmethylated CpG DNA which are recognized by TLR2/1, -3, -4, -
5, -2/6, -7, -8 and -9, respectively. The TLR10 agonist is still unknown [84-86].  The 
 12 
 
major surface TLRs are TLR2/4/5, which are the focus herein.  All TLR signaling 
pathways result in activation of the transcription factor NFκB (nuclear factor-κB) via the 
myeloid differentiation primary response 88 (MyD88) or TIR-domain-containing 
adapter-inducing interferon-β (TRIF) (Figure 2).  MyD88 and TRIF are the major 
adaptors that bind to the intracellular domain of TLRs [87, 88].  TLRs use different 
combinations of adaptors to activate unique pathways for the elimination of pathogens 
[89, 90].   Once a MAMP is recognized by PRRs on innate immune cells, an 
inflammatory response is elicited at the site of infection.  Neutrophils and 
macrophages/monocytes are primary responders of the innate system.  They have the 
ability to phagocytize antigens and release molecules for the recruitment of additional 
immune cells and other molecules to destroy the invading microbe [91, 92].  
As our immune system has evolved to combat microbes, microbes have adapted 
strategies of their own to subvert the immune system.  Several strategies are utilized in 
avoidance of the immune system including secretion of proteases to degrade cytokines 
and host receptors, modification of the molecular structure of their MAMPs to avoid 
recognition by PRRs and protein secretion systems that deliver virulence factors into the 
host cells to down regulate immune responses.   
Certain pathogens are capable of targeting major signal transduction pathways, 
including the NFκB and MAPK pathways.  Bacillius anthracis lethal factor (LF) directly 
inhibits MAPK pathways by cleaving the amino terminus on MAPKK1 and -2 [93].  
Shigella spp. are capable of surviving within host macrophages where they inhibit the 
NFκB pro-inflammatory pathway through release of its Type III effector molecule, OspL 
[94].  Extracellular bacteria such as enterohemorrhagic Escherichia coli (EHEC) also 
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inhibit the MAPK-NFκB pathway by releasing translocated intimin receptor (Tir) into the 
host. Tir mimics immunoreceptor tyrosine-based inhibition motifs (ITIMs), which leads 
to the recruitment of Src-homology-region-2-domain-containing phosphatase 1 (SHP-1) 
that directly dephosphorylates NFκB and MAPK [95]. 
While it has been established that RagB is recognized by the immune system, the 
inflammatory potential of RagB is unknown.  The main objective of this study was to 
determine the inflammatory potential of RagB and to unravel any underlying pro-
inflammatory mechanisms.  We determined that RagB elicits a pro-inflammatory 
response, via TLR-2 and -4, and activates transcription factors STAT4 and NFκB, which 
then leads to production of pro-inflammatory mediators at the transcriptional and protein 
levels including IL-6, TNF and IL-8. We also add evidence to the important role of ragB 





       
Figure 2. Activation of the NFκB pathway by TLR2 and -4. 
 
Diagram represents the activation of NFκB complex via surface expressed TLR2 and -4 
in a human monocyte. Agonists recognized by TLRs lead to the phosphorylation of IκB 
which then degrades allowing the p50/p65 complex to travel directly to the nucleus for 






CHAPTER TWO:  MATERIALS AND METHODS 
 
Materials 
Gifu Anaerobe Medium (GAM) was purchased from Nissui Pharmaceutical (Tokyo, 
Japan). ∆ragB and ∆ragB/W83 complement strains were a generous gift from Dr. 
Fuminobu Yoshimura [74]. P. gingivalis specific antibodies were a kind gift from Dr. 
Richard Lamont, and the E.coli DH5α with pSAM was a kind gift from Dr. Debbie 
Yoder-Himes [96].  Basal media was purchased from Lifeline Cell Technology 
(Frederick, MD). Sheep blood was purchased from Lampire Biological Laboratories 
(Pipersville, PA). Nu-PAGE 4-12% Bis-Tris gels, PBS, RPMI-1640, DMEM, expression 
plasmid pBAD kit, PCR supermix, EKmax and EKaway resin were purchased from 
Invitrogen (Carlsbad, CA).  LB broth and agar were purchased from BD Biosciences 
(San Jose, CA). Anti-TLR2 (clone B4H2) and -4 (clone W7C11) antibodies, Quanti-Blue 
NFκB assays, Hygro-Gold, blasticidin, Normocin, Zeocin, Ultra Pure LPS-EK, Human 
TLR agonist kit were purchased from Invivogen (San Diego, CA). The anaerobic 
chamber was bought from Coy Laboratories (Grass Lake Charter Township, MI).  
Ampicillin, gentamicin, erythromycin, tetracycline, RIPA buffer, phosphatase and 
proteinase inhibitor cocktails, arabinose, E.coli LPS, metronidazole, HEPES buffer, 
sodium bicarbonate, sodium pyruvate, streptomycin and phallodin-TRITC stain were 
purchased from Sigma-Aldrich (St. Louis, MO).  Fetal bovine serum (FBS) was 
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purchased from Atlanta Biologicals (Flowery Branch, GA). RNA purification kit was 
purchased from 5-Prime (Gaithersburg, MD).  All primers were ordered from 
Biosynthesis Inc. (Lewiston, TX).  ImageQuant LAS 4010, HiTrap Chelating HP column 
was from GE Healthcare (Piscataway, NJ). Anti-p-p65, p-STAT4, p65, STAT4, β-actin 
antibodies were purchased from Cell Signaling Technology (Beverly, MA). Anti-TLR2 
and -TLR4 antibodies, siRNA TLR2, TLR4, p65, STAT4 and control were purchased 
from Santa Cruz Biotechnology (Santa Cruz, CA). Coomassie Blue stain and PVD 
membrane were purchased from Bio-Rad Laboratories (Hercules, CA). Signaling 
Pathway RT
2
 Profiler PCR arrays, SYBR Green Supermix with ROX were purchased 
from Qiagen (Valencia, CA). Quanta cDNA synthesis mix from Quanta BioScience 
(Gaithersburg, MD). IL-6, -8, IFNγ, IL-4, 12, TNF Elisas purchased from eBioscience 
(San Diego, CA).  GeneChip® 3’ IVT Express kit from Affymetrix (Santa Clara, CA). 
NanoDrop Spectrophotometer ND-1000 from Thermo Scientifc (Wilmington, DE); (R)- 
lisofylline was purchased from Cayman Chemical (Ann Arbor, MI). p65(Ser276) and 
control peptide inhibitors were from Novus Biologicals (Littleton, CO).  4-D 
Nucleofactor system, P3 primary transfection kit were purchased from Lonza (Rockland, 
ME). CD14 I and II isolation kits were purchased from Miltenyi Biotec (San Diego, CA). 
Lymphocyte separation medium (LSM), Triton X, 2-mercaptoethanol, 4-chambered 
slides, Pro-Long Gold with DAPI stain were purchased from Fisher Scientific 
(Pittsburgh, PA). Genomic DNA isolation kits were purchased from Promega (Madison, 
WI). Fluoview FV1000 confocal system was purchased from Olympus (Center Valley, 
PA). 1% paraformaldehyde solution was purchased from Electron Sciences Microscopy 
(Hatfield, PA). ABI 7500 Real-Time PCR machine from Applied Biosystems, 
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Supersignal West Pico Chemiluminescent substrate, Slide-A-Lyzer Dialysis Cassette, 
10K MWCO, trypan blue and BCA Protein Assay kit were purchased from Thermo 
Fisher Scientific (Rockford, IL).  
 
Bacterial culture 
Porphyromonas gingivalis strains W83 and 33277 were purchased from American Type 
Culture Collection (Manassas, VA) and maintained in GAM broth.  ∆ragB and 
pTCBex2:ragBW83-carrying complemented P. gingivalis strains have been described 
previously [74]. P. gingivalis strains were maintained in a Coy Laboratories anaerobic 
chamber (80% N2, 10% H2, 10% CO2) at 37°C.  E.coli TOP10 strain was maintained 
aerobically in LB broth or LB agar plates at 37°C.  Purity of bacterial cultures were 
routinely screened by Gram stain. 
 
Isolation and maintenance of human cells 
Whole blood was isolated from healthy donors (≥ 18 years; ≥49.9 kg; free of any chronic 
health problems; medication free; not pregnant) who provided written, informed consent 
as approved by the Institutional Research Board at the University of Louisville.  Buffy 
coat was collected from an LSM gradient, washed in PBS (10mM, pH 7.2) and 
monocytes were harvested from PBMCs using Milentyi CD14 magnetic beads.  Viability 
was routinely >98%, as assessed by trypan blue exclusion.  Monocyte cells were 
resuspended in RPMI 1640 containing penicillin (100 µg/ml), streptomycin (100 µg/ml) 
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and 10% FBS.  Monocytes were incubated at 37°C in 5% CO2 overnight prior to 
stimulation. 
THP-1 and THP-1 XBlue NF-kB/AP-1 SEAP reporter cell lines were maintained in 
RPMI 1640 at 37°C 5% CO2.  THP-1 XBlue cells were maintained with the addition of 
Zeocin (200 µg/ml).  HEK 293 (human embryonic kidney) cells were maintained in 
DMEM with the addition of 10% FBS.  HEK TLR 2/1, 2/6, 5 and null cells were 
maintained with blasticidin (100 µg/ml) and Normocin (10 µg/ml), whileTLR4-MD2-
CD14 cells were maintained with blasticidin (100 µg/ml), Normocin (10 µg/ml) and 
HygroGold (50 µg/ml).  The TIGK (telomerase immortalized gingival keratinocytes) cell 
line was a kind gift from Dr. Richard Lamont (University of Louisville).  TIGKs were 
maintained at 37°C 5% CO2 in basal media. 
 
Production and purification of RagB 
P. gingivalis W83 genomic DNA was purified using Promega Isolation kits and the ragB 
gene was amplified by PCR (Fwd: CACCGAGCTTGACCGCGACCCC; Rev: 
TATCGGCCAGTTCTTTATTAACTGCGG).  The ragB product was gel purified on a 
1% agarose gel and transformed into E.coli TOP10 strain using the pBAD202D TOPO 
vector and TOPO expression kit, according to manufacturer’s instructions.  
Transformants were plated on LB agar plates containing 50 µg/ml of kanamycin.  PCR 
was used to confirm uptake of ragB in selected colonies.  E.coli containing ragB were 
grown in LB broth and RagB expression was induced by arabinose.  Cells were then 
pelleted and lysed using CellLytic B buffer.  The recombinant his-tagged RagB was 
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collected by column purification (300nM imidazole fraction; HiTrap Chelating HP 
column) and dialyzed using a Thermo Slide-A-Lyzer Cassette 10000 MWCO in PBS.  
The dialyzed product was checked for purity by both SDS-PAGE gel (Figure 3) and mass 
spectrometry, performed at the Mass Spectrometry Core Laboratory (University of 
Louisville, KY). Lack of biologically meaningful protein contamination and other 
pyrogens was confirmed by analysis of cytokine release from monocytes exposed to 
denatured (SDS-treated) and heat-treated (boiled) RagB preparations (Figure 4). 
 
RagB stimulation of IL-8 and NFκB in THP-1 cells 
 THP-1 cell lines were maintained in buffered RPMI 1640.  The THP-1 and THP-1 XBlue 
cell lines were plated in 96 well plates at ~500,000 cells per well.  Cells were stimulated 
with RagB (0, 1, and 10 µg/ml) and cell-free supernatant were harvested ~20 hour post 
stimulation.  THP-1 supernatant was use to analyze IL-8 production by ELISA 
(eBioscience).   THP-1 XBlue supernatant was used to measure NFκB production by the 
use of Quanti-Blue assays (measured at 595nm wave length). THP-1 XBlue cells contain 
a NFκB/AP-1 inducible reporter system which is used with Quanti-Blue assays to 
measure NFκB/AP-1 activation via secreted embryonic alkaline phosphatase (SEAP) 
reporter gene.   E.coli LPS was used as a positive control for IL-8 and NFκB production.   
 
RagB stimulation of cytokines from TLR-transfected HEK-293 cells 
HEK cells were grown to ~80% confluence in 96 tissue culture plates.  HEK transfected 
hTLR2/1, 2/6, 4 and 5 cell lines were stimulated with their respective agonist 
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(Pam3CSK4, FSL1, LPS and FLA-ST) and RagB (1 µg/ml). HEK null cells were used as 
a negative control and stimulated with each TLR agonist and RagB, but did not induce 
IL-8 production. Cell-free supernatants were collected 20 hours post stimulation.  IL-8 
production was measured by ELISA.   
 
Quantification of RagB-induced cytokines in primary human monocytes 
Isolated monocytes were plated in 96 well plates at 300,000 cells/well.  Cells were 
allowed to rest overnight at 37°C in 5% CO2 and then stimulated with Rag B (0.1, 1 or 10 
µg/ml) or E.coli LPS (0.1 and 1 µg/ml). Cell free supernatants were harvested following 
centrifugation 20 h post stimulation.  ELISAs were used to measure IL-8, IL-6, IL-4, IL-
12, IL-10, IFNγ and TNF concentrations in the supernatants.   
 
 Identification of genes activated by RagB in a qRT-PCR TLR array  
 Primary human monocytes were stimulated with RagB (1 µg/ml) for four hours.  RNA 
was harvested with the 5-Prime RNA purification kit.  cDNA was synthesized using 
qScript  cDNA synthesis kit and then run on a thermal cycler under the following 
conditions:  22°C for 5 mins, 42°C for 30 mins, 85°C for 5 mins. One tenth of the first-
strand reaction was used for the 96 well TLR Focused RT-PCR array plate, which allows 
for analysis of message derived from 84 genes in the human TLR pathway.  SYBR® 
Green with ROX master mix was used as the fluorescence dye.  An ABI 7500 RT-PCR 
machine was used to read the plate.  Each plate contained 5 housekeeping controls and 
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the RagB stimulated plate was compared with the unstimulated control plate.  2
-∆∆Ct
 value 
was calculated.   
 
Identification of genes activated by RagB in primary human monocytes by whole 
genome arrays 
Whole genome microarrays were used to determine the transcriptomic response of 
primary human monocytes to RagB.  Cells were plated in triplicate on 6 well plates at 
4x10
6
 cells/well.  Cells were stimulated with 0, 1, or 10 µg/ml of RagB.  RNA was 
harvested by 5-Prime RNA isolation kit four hours post stimulation.  Total RNA (100 ng) 
was used per array.  Following the manufacturer’s protocol:  RNA was used to synthesize 
first-strand cDNA (2hr incubation) and then synthesized to second-strand cDNA (1hr 
incubation).  In vitro transcription of aRNA (amplified RNA) that was biotin labeled with 
an incubation period of 1 hr at 16°C and 10 mins at 60°C.  aRNA was purified to remove 
any salts or remaining free nucleotides. aRNA was then fragmented and incubated at 
94°C for 35 mins.  The fragmented product was hybridized to the GeneChip 3’ arrays.  
Arrays were scanned using Command Console 3.2 (Affymetrix, St. Clara, CA).  Each 
group was measured in triplicate and the averages were taken. Files were imported into 
Genomics Suite 6.6 (Partek Inc., St. Louis, MO) for summarization and background FDR 
correction.  One way ANOVA was used to compare the different treatments.  Ingenuity 
IPA software (Redwood City, CA) was used to filter genes with ±2 fold change, dose-
dependent response (10 >1 >0 g/ml RagB) and P value < 0.001.  243 differentially 
regulated genes were identified.  Ingenuity software was used to look at gene clusters and 
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qRT-PCR validation of RagB-regulated genes 
Primary human monocytes were stimulated with 0 or 1 µg/ml of RagB.  RNA was 
harvested using the 5-Prime RNA purification kit four hours post stimulation.  RNA 
concentrations were  measured by Nanodrop.  cDNA was synthesized by qScript cDNA 
synthesis kit (Quanta).  RT-PCR cycle conditions were as follows: 2 mins at 50°C; 10 
mins at 95°C; 15 sec at 95°C, 1 min at 55°C for 40 cycles.  An ABI-7500 RT-PCR 
machine was used to run the samples.  Primer sequences (Table 1) were designed using 
Primer-BLAST (www.nchi.nlm.nih.gov/tools/primer-blast). 
Genes Forward Primer  Reverse Primer 
IL-6 TGCAATAACCACCCCTGACC GTGCCCATGCTACATTTGCC 
IL-1α CAGGAGCTTGTCACCCCAAA CATGGAGTGGGCCATAGCTT 
CCL20 CAGTGCTGCTACTCCACCTC TTGGACAAGTCCAGTGAGGC 
IL-1β CGCTCCGGGACTCACAGCAA GGTCCCTCCCAGGAAGACGGG 
IL-12β TCAAACCTGACCCACCCAAG TCAGAACCTAACTGCAGGGC 
IL-8 AGTCCTTGTTCCACTGTGCC CACAGCACTACCAACACAGC 
STAT-4 ATAAGAGGGAAGAGGACGCC ACATGCTAGCGCTCTCTCAG 
RagB CACCGAGCTTGACCGCGACCCC  TATCGGCCAGTTCTTTATTAACTGCGG 
GAPDH GCCGCATCTTCTTTTGCGTC TCGCCCCACTTGATTTTGGA 
 
Table 1.  Primer sequences. 
Primers used to verify select RagB-regulated monocyte genes identified by microarray 





TLR specificity of RagB in primary human monocytes 
Monocytes were plated in 96 well plates (300,000 cells/well) and allowed to rest 
overnight.  Monocytes were pre-treated for one hour with 1 µg/ml of anti-TLR2 or -4 
blocking antibodies.  Cells were then stimulated with RagB (1 µg/ml) and the TLR2 and 
-4 agonists (HKLM at 10
8
 cells/ml and LPS-EK at 1 µg/ml).  Cell free supernatants were 
harvested 20 hours post stimulation.  ELISA was used to measure cytokine production. 
 
Inhibition of STAT4 in RagB-stimulated primary human monocytes 
Primary human monocytes were pre-treated with the STAT4 inhibitor, lisofylline (LSF), 
for one hour.  Cells were then stimulated with RagB (1 µg/ml) and cell-free supernatants 
were harvested 20 hours post stimulation.  Cytokine production was measured by ELISA.   
 
Inhibition of NFκB (p65) in RagB-stimulated primary human monocytes 
Primary human monocytes at 300,000 cells/well in 96 well plates were untreated or 
exposed to combinations of RagB (1 µg/ml) or E. coli LPS  (1 µg/ml) and a p65 or 
negative control peptide inhibitor set (100 µM , 1 hr pre-treatment). Cell free 
supernatants were harvested 20 hours post stimulation.  Cytokine production was 






TLR2, TLR4, p65 and STAT4 gene silencing  
TLR2, TLR4, p65 and STAT4 genes were individually silenced in human monocytes by 
siRNA transfection using the 4D-Nucleofactor system, according to the manufacturer’s 
P3 primary cell protocol.  A control siRNA scrambled sequence was used as a negative 
control. Briefly, ~4 million cells were suspended in 100 µl transfection reagent in single 
nucleocuvettes and 3 µl (30 pM) of siRNA added.  Transfected monocytes were rested in 
RPMI 1640 containing 10% FBS for 48 h at 37°C prior to stimulation with RagB and 
other agonists, as described in the figure legends (9-12).  Confirmation of gene silencing 
was performed by Western blot analysis as shown in Figures 9, 11-12. 
 
Colonization of epithelial cells by wildtype and ∆ragB P. gingivalis strains 
TIGK cells were used as a model to study bacterial interactions with gingival epithelial 
cells.  TIGKs were plated in 12 well plates or 4-chambered glass slides until 80% 
confluence was attained. TIGKs were maintained in basal media.  P. gingivalis strains  
(W83, ∆ragB, and complement) were used to infect the TIGKs at MOI of 10:1 for one 
hour.  Cells were then washed with PBS and basal media containing gentamicin (300 
µg/ml) and metronidazole (200 µg/ml) was added for one hour.  TIGK cells were then 
lysed and lysates plated on GAM/blood agar or fixed with paraformaldehyde for confocal 
analysis. CFUs were enumerated after seven days of anaerobic incubation. Unexposed 
TIGKs were used as a negative control.  Paraformaldehyde 4% was added to the 
chambered wells for 20 minutes.  Cells were washed with PBS and 0.2% Triton X-100 
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was added for 10 mins.  Wells were washed with PBS, and 10% horse serum was added 
for 20 mins.  Primary anti-P. gingivalis antibodies were added at 1:1000 for one hour.  
Wells were then washed with PBS and the secondary antibody (anti-rabbit; 1:200) was 
added for one hour.  Wells were washed with PBS and phalloidin-TRITC (1:100) was 
added for 40 minutes.  Wells were then washed with PBS and coverslips were mounted 
using Prolong Gold with DAPI and allowed to cure overnight.  Slides were viewed using 
Fluoview FV1000 confocal system at 60X magnification.   
 
Induction of cytokines by wildtype and ∆ragB P. gingivalis in monocytes 
 Bacterial strains W83, ∆ragB, and complement were harvested at late log phase.  Cells 
were washed with PBS and fixed in 1% paraformaldehyde for one hour.  Bacterial cells 
were fixed prior to cell stimulation to control for the degradation of cytokines by bacterial 
proteases.  After fixation, cells were washed in PBS and used to stimulate primary 
monocytes at a MOI of 10:1.  Cell free supernatants were collected 20 hours post 
stimulation for analysis by ELISA.   
 
Preparation of RagB for crystallization 
Purified RagB was digested with 0.1 unit of EKMax per 20 µg of protein.  The reaction 
mixture contained RagB, 10X EKMax Buffer and 0.1 unit of EKMax.  The mixture was 
incubated at 37°C for 16 hours.  EKMax was removed using EK-Away resin.  Briefly, 
EK-Away resin was added to the mixture for two minutes and then pelleted.  The 
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supernatant was removed and the pellet resuspended in EK-Away Resin for another two 
minutes.  EK-Away 1X buffer was added and EK-Away Binding buffer was added to the 
Enterokinase digestion mixture for 15 minutes and centrifuged.  The supernatant was run 
on SDS-PAGE gel and stained with Coomassie Blue to verify the correct size.  Products 
were then concentrated and sent for crystallization.  Pymol generated the image, and the 
analysis is currently being performed by our collaborator, Dr. Theodoros Goulas 
(Structural Biology, Molecular Biology Institue of Barcelona, Spain).   
 
Statistical analysis 
All experiments were performed in triplicate unless otherwise stated.  Data were analyzed 
by student t-test or one-way ANOVA using GraphPad and Prism 4 software.  P value less 
than or equal to 0.05 was considered to represent statistically significant differences 







CHAPTER THREE:  RESULTS 
 
 
RagB production and purification 
  
Purified, recombinant RagB protein was shown to be free of contaminants first by 
using a NuPAGE gel stained with both Coomassie Blue and silver staining techniques 
(Figure 3).  Subsequently, the RagB band was extracted and sequenced using mass 
spectrometry to confirm the presence of a single amino acid sequence homologous to that 
expected for RagB.  Primary human monocytes were used to test denatured RagB for 
possible LPS, or other pyrogen, contamination by heat-denaturing the protein at 80°C for 
20 mins or treating the protein with 10% SDS prior to stimulation.  Heat-denatured and 
SDS treated RagB  did not elicit an IL-8 response in monocytes (Figure 4), further 
verifying the recombinant protein to be free of contamination. IL-8 is a pro-inflammatory 
cytokine that is involved in neutrophil recruitment and its promoter contains both an 






















Figure 3. Purified RagB run on a NuPAGE® Novex® 4-12% Bis-Tris Gel and 
stained with Coomassie Blue and silver stain. 
Purified RagB was run on an NuPAGE 4-12% Bis-Tris gel to check from possible 
contaminants.  Coomassie Blue (1) and silver stains (2) were both conducted.  Only one 
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Figure 4.  Denatured RagB does not elicit a IL-8 response.    
Monocytes were stimulated with RagB (1 µg/ml), LPS (1 µg/ml), SDS treated RagB or 
boiled RagB.  Cell free supernatants were harvested at 20 hrs post stimulation and IL-8 
quantified by ELISA.   
*** p<0.001 compared to the unstimulated control 
 
RagB does not elicit a response in THP-1 and HEK transfected cell lines 
 
Monocytic whole genome array data suggested that RagB induced multiple genes 
known to be regulated by the transcription factor NFκB.  THP-1 cells are monocytic 
leukemic cells commonly used to study innate immunity while THP-1XBlue cells contain 
a reporter plasmid controlled by an NFκB promoter system. Therefore, THP-1 cells were 
challenged with RagB and E.coli LPS was used as a positive control for IL-8 cytokine 
production.  Cell free supernatants were harvested at 20 hours post stimulation.  ELISA 
used to measure the concentration of IL-8 in supernatants.  RagB did not induce an IL-8 
response in the THP-1 cell line (Figure 5).   
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THP-1 XBlue cells were then used to determine if NFκB could be activated by 
RagB.  Quanti-Blue assays were performed on 20 h cell free  supernatants in order to 
measure the induction of NFκB.  There was not a detectable level of NFκB induction in 
THP-1 XBlue cells by RagB as shown in Figure 6.  E.coli LPS was used as a positive 
control for NFκB induction.    
HEK cells are commonly used to identify TLR agonists since they are readily 
transfected and do not naturally express surface TLRs.  HEK hTLR cells stably 
transfected with TLR-2/-1, TLR-2/-6, TLR-4, and TLR-5, as well as null transfected 
HEK control cells were used to measure RagB induction of IL-8.  Cells were 
unstimulated or stimulated with RagB (1 µg/ml) or their respective classical agonists 
(2/1, Pam3CSK4 at 1 µg/ml; 2/6, FSL1 at 1 µg/ml; 4, LPS at 1 µg/ml; 5, FLA-ST at 1 
µg/ml).  Cell free supernatants were collected 20 hours post stimulation.  IL-8 cytokine 
production was measured by ELISA.  RagB induction of IL-8 was not detected in any of 
the surface TLR transfected HEK cell lines, as shown in Figure 7.    
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Figure 5.  RagB does not induce an IL-8 response in THP-1 cells. 
THP-1 cells were stimulated with RagB (1 µg/ml), LPS (0.1 and 1 µg/ml), and boiled 
RagB.  Cell free supernatants were harvested at 20 hrs post stimulation for ELISA.   











































































Figure 6. RagB does not induce NFκB in THP-1 XBlue cell line.   
THP-1 XBlue cells were stimulated with RagB (1 and 10 µg/ml), LPS (0.1, 1 and 10 
µg/ml).  Cell free supernatant was harvested 20 hrs post stimulation.  Quanti-Blue assays 
were used to measure induction of NFκB by secreted alkaline embryonic phosphatase.    




















































































































































Figure 7.  RagB does not signal through surface exposed TLRs in HEK cell lines. 
HEK 293 cells transfected with (A) hTLR 2/1, (B) hTLR 2/6, (C) hTLR 4 and (D) hTLR 
5.  Cells were stimulated with RagB (1µg/ml) and TLR respective agonist.  Cell free 
supernatant was harvested 20 hrs post stimulation and measured by ELISA.    
*** p < 0.001 compared to unstimulated control.  
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RagB induces pro-inflammatory cytokines in primary human monocytes 
 
To measure cytokine levels, primary monocytes were stimulated with RagB (0.1, 
1 or 10 µg/ml) and E.coli LPS (0.1 or 1 µg/ml) for 20 hours. Cell free supernatant was 
harvested for ELISA.  RagB induced a significant, dose-related increase in the IL-8 
response, compared to unstimulated controls (Figure 8).  Similar results were obtained 
for both IL-6 and TNF (Figure 8). This confirms RagB promotes production of pro-
inflammatory cytokines in primary human monocytes.  RagB was also degraded by 
boiling and SDS digestion.  Cells stimulated with degraded RagB did not induce an 





                























































Figure 8. RagB induces pro-inflammatory cytokines in primary innate cells. 
Primary human monocytes were untreated or treated with E. coli LPS (0.1, or 1 µg/ml) or 
with RagB (0.1, 1, or 10 µg/ml).(A) IL-8, (B) IL-6 and (C) TNF (D) IFNγ concentrations 
in 20 hr cell-free supernatants were determined by ELISA. No, or minimal, protein signal 
was observed for IL-10 or IL-12. 





RagB induces multiple pro-inflammatory genes in TLR-focused arrays  
 
In order to understand the mechanisms of pro-inflammatory cytokine induction by 
RegB, we initially used focused arrays to screen for RagB activation of 84 major TLR 
pathway-related genes.  Primary human monocytes were stimulated with 0 or 1 µg/ml 
RagB and total RNA was harvested four hours post stimulation.  Additionally, LPS 1 
µg/ml was used as a positive control.  cDNA was synthesized and used in RT-PCR-
based, TLR-focused arrays.  Each set of TLR genes were compared to 5 housekeeping 
genes and the 2 
-ΔΔct
 method [98] was used to compare unstimulated vs stimulated groups.  
The pro-inflammatory genes encoding IL-1β, IL-8, IL-1, CCL2, and IL-6 were each 
shown to be upregulated in cells stimulated with RagB as shown in Table 2.  The genes 
CCL2, CLEC4E, HSPA1A, IL-1α, IL-8, NFᴋB1A, PTGS2 and REL were shown to be 





Gene Description Fold change 
IL-1β Interleukin 1, beta 83.4 
IL-8 Interleukin 8 35.3 
IL-1α Interleukin 1, alpha 18.7 
CCL2 Chemokine (C-C motif) ligand 2 7.1 
IL-6 Interleukin 6 5.8 
 
Table 2. RagB induces multiple TLR-related genes in primary human monocytes. 
RNA was harvested 4 hr post treatment and reverse transcribed for hTLR RT-PCR array. 
The 2 
-ΔΔct
 method was used to determine significant differences from the control 
(unstimulated) group. 5 of the 84 genes in the TLR Signaling Pathway RT² Profiler PCR 






Gene Description Fold Change 
CCL2 Chemokine (C-C motif) ligand 2 14.0 
CLEC4E Colony stimulating factor 2 (granulocyte-macrophage) 19.1 
HSPA1A Heat shock 70kDa protein 1A 2.6 
IL-1α Interleukin 1, alpha 80.2 
IL-8 Interleukin 8 196.2 
NFKBIα Nuclear factor of Kappa light polypeptide gene chancer in B-cells 
inhibitor, alpha 
19.4 
PTGS2 Prostaglandin-endoperoxide synthase 2 290.0 
REL V-rel reticuloendotheliosis viral oncogene homolog 17.6 
 
Table 3. LPS induces multiple TLR-related genes in primary human monocytes. 
RNA was harvested 4 hr post treatment and reverse transcribed for hTLR RT-PCR array. 
The 2 
-ΔΔct
 method was used to determine significant differences from the control 
(unstimulated) group. 8 of the 84 genes in the TLR Signaling Pathway RT² Profiler PCR 
array were upregulated, as noted above 
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RagB induces multiple pro-inflammatory genes in a dose-dependent manner in 
whole genomic microarrays 
 
Focused TLR arrays identified RagB-induced pro-inflammatory mediators, but 
did not provide any insights on the underlying mechanisms involved in cytokine 
induction.  Therefore, we next determined the whole genomic response of primary human 
monocytes to RagB stimulation.  Monocytes were stimulated with 0, 1 or 10 µg/ml of 
RagB for four hours and total RNA was harvested.  The results were filtered by 
Bonferroni correction and genes were considered differentially regulated if there was ±2 
fold change in message level at each dosage when compared to the unstimulated control, 
and a dose-related response (i.e. the induced signal at 10 g/ml was > 1g/ml which was 
> 0 g/ml) that was statistically significant ( p  <0.001).  The filtered list contained 243 
genes, of which selected upregulated genes are presented in Table 4.  Genes selected are 
implemented in NFᴋB/STAT pathways suggesting a possible signaling mechanism of 
RagB-induction. These selected genes were verified by real-time PCR, again, as shown in 
Table 4.  Similar results were obtained in the RT-PCR array (Table 2) for IL-6, IL-8 and 
IL-1β.  STAT4 was shown to be the most upregulated transcription regulator, 
coincidently, is connected to many of the most upregulated genes as shown in Figure 9.  
This suggests RagB promotes a strong pro-inflammatory signal that could activate 





        
  Fold Change 
  Microarray RT-PCR 
Gene 1vs0 10vs0 1vs0 
IL-6 612 800 153 
CCL20 380 449 34 
IL-1β 295 311 113 
IL-12β 146 765 2.8 
STAT4 35 51 6 
TNF 24 32 9 
IL-8 7.3 7.5 2.7 
   
Table 4. RagB induces multiple pro-inflammatory genes in dose-related manner. 
Primary human monocytes were stimulated with 0, 1 or 10 μg/ml of RagB. RNA was 
harvested 4 hr post-stimulation and used for microarray analysis. 243 genes were 
differentially regulated, as determined by Bonferroni correct p-value, and also exhibited a 
dose-related response (10 > 1 > 0 μg/ml RagB). Selected genes were verified by RT-
PCR. RT-PCR was analyzed by 2
-ΔΔCt






Figure 9. Pathway analysis of the top differently regulated genes in relationship with 
STAT4. 
Ingenuity pathway analysis displaying genes identified by microarray analysis to be 
associated with the transcription regulator, STAT4.  Genes in red are upregulated, and 
genes in green are down regulated.  Solid lines indicate direct interactions between genes, 
and dashed likes indicate indirect interaction between genes.  
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RagB induction of IL-8 is TLR2-dependent 
 
Toll-like receptors (TLRs) play a major role in microbial recognition and innate 
immune signaling.  Previous studies have shown TLRs to be essential in P. gingivalis 
induced infections [65, 99, 100].  TLR2 was shown to be required for P. gingivalis 
induced oral bone loss using TLR2-knockout mice[101].  To investigate the potential 
engagement of TLR-2 by RagB, anti-hTLR2 antibodies were used to block binding of 
TLR-2 agonists to primary human monocytes.  Anti-TLR2 and IgA2 (isotype control) 
antibodies were added at 1 µg/ml for one hour prior to RagB stimulation.  RagB (1 
µg/ml) was used to stimulate the cells and cell free-supernatants were harvested 20 hours 
post stimulation.  The classic TLR-2 agonist, Pam3CSK4, was used as a positive control.  
Cells exposed to anti-TLR2 antibodies then RagB showed a significant decrease in IL-8 
production when compared with cells stimulated with RagB alone (Figure 10).  IgA2 
isotype control did not influence RagB-induced IL-8 production.  This suggests RagB 
induces IL-8 production at least partially through TLR2. 
To confirm TLR-2 engagement by RagB, a second experimental approach was 
adopted, i.e., gene silencing.  Primary human monocytes were transfected with 30 pM of 
control (non-targeting negative control) or TLR-2-specific siRNA.  Cells were allowed to 
rest for 48 hours and then stimulated with RagB (1 µg/ml) for 4 or 20 hours.  Total 
protein was harvested at 4 hours post stimulation and cell free supernatant was harvested 
at 20 hours post stimulation.  Successful TLR-2 silencing was confirmed by Western blot 
and the subsequent reduction of IL-8 induction upon RagB stimulation in silenced cells is 
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Figure 10. RagB induction of IL-8 is TLR2-dependent. 
Primary human monocytes were untreated or exposed to combinations of RagB (1 
μg/ml); the TLR2 agonist, Pam3CSK4 (1 μg/ml), anti-TLR2 (1 μg/ml, 1 hr pre- 
treatment) and control (IgA2, 1μg/ml, 1 hr pre-treatment) antibodies. In an alternative 
strategy, TLR2 gene silencing was performed, as described in the text. (A) IL-8 
concentrations in 20 hr cell-free supernatants were determined by ELISA. TLR2 
knockdown was confirmed by (B) Western blot and (C) densitometry. (D) Inhibition of 
RagB induced IL-8 upon TLR2 gene silencing was determined by ELISA. 







RagB induction of IL-8 is TLR4-dependent 
 
To investigate the potential engagement of TLR4 in the innate response to RagB, 
anti-TLR4 antibodies were used to block TLR4 agonists to primary human monocytes.  
Anti-TLR4 and IgG1 (isotype control) antibodies were added at 1 µg/ml for one hour 
prior to RagB stimulation.  The classic TLR4 agonist, LPS, was used as a positive 
control.  Cells exposed to anti-TLR4 antibodies then RagB showed a significant decrease 
in IL-8 production when compared with cells stimulated with RagB alone (Figure 11)  
IgG1 isotype control did not influence RagB-induced IL-8 production.  This suggests 
RagB induction of IL-8 is at least partially though TLR4.   
We attempted to confirm TLR4 engagement by RagB using a second 
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Figure 11. RagB induction of IL-8 is TLR4-dependent. 
Primary human monocytes were untreated or exposed to combinations of RagB (1 
μg/ml); the TLR4 agonist, LPS (1 μg/ml), anti-TLR4 (1 μg/ml, 1 hr pre- treatment) and 
control (IgG1, 1μg/ml, 1 hr pre-treatment) antibodies.  IL-8 concentrations in 20 hr cell-




RagB induction of IL-8 is STAT4-dependent 
 
Genomic microrarrays identified STAT4 as a potentially important transcription 
regulator in the RagB-induced innate response.  STAT4 has previously been shown to 
play a critical role in inflammation in monocytic cells [102]. Thus, the STAT4 inhibitor, 
LSF, was used to pharmaceutically inhibit STAT4 in cells stimulated with RagB.  
Primary human monocytes were pre-treated with LSF (25 or 100 µM) for one hour.  Cells 
were then stimulated with RagB (1 µg/ml).  Cell free supernatants were harvested 20 
hours post infection for detection of IL-8 by ELISA.  LSF significantly suppressed the 
induction of IL-8 by RagB.   
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In addition to pharmaceutical inhibition of STAT4, gene silencing by siRNA was 
also used to investigate RagB signaling.  Primary human monocytes were transfected 
with 30 pM of control or STAT4-specific siRNA.  Cells were allowed to rest for 48 hours 
and then stimulated with RagB (1 µg/ml) for 4 and 20 hours.  Total protein was harvested 
at 4 hours post stimulation and cell free supernatant was harvested at 20 hours post 
stimulation.  There was a decrease in total STAT4 protein at 4 hours and a significant 
decrease in IL-8 production in cells stimulated with RagB transfected with STAT4 
siRNA (Figure 12).   This strongly suggests RagB signals though STAT4 in the context 
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Figure 12. RagB-induction of IL-8 is STAT-dependent. 
Primary human monocytes were untreated or exposed to combinations of RagB (1 μg/ml) 
and the STAT4 inhibitor, LSF (25 and 100 μM, 1 hr pre- treatment). STAT4 gene 
silencing was performed, as described in the text. (A) IL-8 concentrations in 20 hr cell-
free supernatants were determined by ELISA. STAT4 knockdown was confirmed by (B) 
Western blot and (C) densitometry. (D) Inhibition of RagB induced IL-8 on STAT4 gene 
silencing was determined by ELISA.  







RagB induction of IL-8 is NF-kB (p65)-dependent 
 
The NFκB transcriptional pathway is the best defined major pathway controlling 
pro-inflammatory responses to pathogens and MAMPs.  An NFκB p65 (Ser276) inhibitor 
peptide was used to block phosphorylation of the NFκB complex in cells stimulated with 
RagB.  The peptide inhibitor acts as a p65 decoy through the phosphorylation of the 
Ser276 site located on the peptide.  Primary human monocytes were pre-treated with p65 
or control peptide one hour prior to stimulation with RagB (1 µg/ml) or E.coli LPS (1 
µg/ml).  LPS is a typical TLR4 agonist thus was used as a positive control for NFᴋB 
induction.  Cell free supernatants were harvested 20 hours post stimulation and their IL-8 
content quantified by ELISA.  The IL-8 response in RagB stimulated monocytes was not 
influenced by a negative control peptide.  The p65 peptide inhibitor, on the other hand, 
significantly suppressed the induction of IL-8 by RagB.   
Again, a gene silencing approach was taken in order to confirm the importance of 
p65 in the inflammatory response of primary innate cells to RagB.  Primary human 
monocytes were transfected with 30 pM of control or p65-specific siRNA.  Cells were 
allowed to rest for 48 hours and then stimulated with RagB (1 µg/ml) for 4 or 20 hours.  
Total protein was harvested at 4 hours post stimulation and cell free supernatant was 
harvested at 20 hours post stimulation.  There was a decrease in total p65 protein at 4 
hours and a significant decrease in IL-8 production in cells stimulated with RagB 
transfected with p65 siRNA (Figure 13).   This strongly suggests RagB signals though 
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Figure 13. RagB-induction of IL-8 is NFκB (p65)-dependent. 
Primary human monocytes were untreated or exposed to combinations of RagB (1 μg/ml) 
and a p65 peptide inhibitor set (100μM, 1 hr pre- treatment). p65 gene silencing was 
performed, as described in the text. (A) IL-8 concentrations in 20 hr cell-free 
supernatants were determined by ELISA. p65 knockdown was confirmed by (B) Western 
blot and (C) densitometry. (D) Inhibition of RagB induced IL-8 on p65 gene silencing 
was determined by ELISA. 







RagB induces phosphorylation of STAT4 and p65 
 
The phosphorylation of proteins is essential in the regulation of biological 
pathways including the NFᴋB (p65) and STAT4 proteins, which become activated once 
phosphorylated and are able to travel to the nucleus for transcription [103, 104].  To 
confirm activation of STAT4 and p65, total protein was harvested at 0, 15, 30, 60, 90, 
120, and 180 minutes post-RagB (1 µg/ml) stimulation of primary human monocytes.  
Western blot analysis showed p65 activation as early as 15 minutes post-RagB 
stimulation with STAT4 phosphorylation occurring shortly after p65 activation (Figure 
14).  This suggests NFᴋB may potentially be activating STAT4 once it becomes 
phosphorylated.  A previous study has shown STAT4 to contain NFᴋB binding sites and 






Figure 14. RagB induces the phosphorylation of STAT4 and p65. 
Primary human monocytes were treated with 1 μg/ml RagB and total proteins were 
harvested. Western blot of proteins harvested at 0, 15, 30, 60, 90, 120, and 180 mins 
using STAT4 and p65 phosphorylated antibodies. β-actin was used as a loading control.   




ΔragB mutant induces weaker inflammatory response than wild type P. gingivalis 
 
The recombinant form of the RagB protein was shown to induce a strong pro-
inflammatory response in primary human monocytes. However, it is also important to 
establish the inflammatory potential of RagB in the context of the whole bacterium.  W83 
wild type, W83 ΔragB and ragB complemented strains were used to stimulate primary 
monocytes.  A recent study has shown live P. gingivalis secretion of gingipains to 
degrade IL-8 cytokines [106], thus, bacterial cells were fixed in 1% paraformaldehyde for 
one hour prior to stimulation to control for cytokine degrading due to gingipains.  
Monocytes were challenged with bacteria (MOI 1:10) and cell-free supernatants were 
harvested 20 hours post-stimulation.  ΔragB mutants displayed a significant reduction in 
cytokine response in the context of IL-8 in comparison to both wild type and ragB 
complemented bacteria.  Similar results were obtained for TNF and IL-6 (Figure 15).  
Thus, similarly to purified, recombinant RagB,   ragB appears to induce a robust pro-


































































































Figure 15. ΔragB mutant induces weaker inflammatory response than wild type 
strain.   
Primary monocytes were stimulated with MOI 10:1 fixed P. gingivalis strains for 20 h 
and cell free supernatant was collected. (A) IL-8, (B) IL-6 and (C) TNF concentrations 
determined by ELISA. 




ΔragB mutants are unable to colonize TIGKs 
 
Previous studies have suggested ragB to be important in P. gingivalis virulence, 
particularly, epithelial cell invasion.  To investigate the contribution of ragB to cell 
invasion, we challenged an oral epithelial cell line (TIGK cells) with wild type, ΔragB 
and complemented ragB strains.  TIGKs were challenged with bacteria for 1 hour then 
antibiotics were added to kill any remaining extracellular bacteria.  After one hour, cells 
were lysed and plated on GAM/blood agar plates for CFU enumeration.  The ΔragB and 
complemented CFU counts were significantly lower than the parental, wild type strain 
(Figure 16).  This provides evidence that ragB may play a role in the colonization of host 
cells.   





















Figure 16. ΔragB mutant exhibits lower colonization rate than wild type in TIGKs. 
TIGKs were plated in 12 well plate.  TIGK cells were unexposed or exposed to W83, 
ΔragB and complemented strains for 1 hr at MOI 10:1.  Cells were washed with PBS and 
media was replaced with basal media containing gentamicin (300 µg/ml) and 
metronidazole (200 µg/ml) for 1 hr.  Cells were then lysed and supernatants were plated 
on GAM/blood agar and incubated anaerobically at 37°C for 7 days.  CFU were then 





Confocal microscope analysis of P. gingivalis ΔragB inability to colonize TIGKs 
 
To investigate the importance of ragB in epithelial cell colonization, TIGK cells 
were uninfected or challenged with wild type and ΔragB strains at an MOI of 10:1 for 
one hour.  Antibiotics were used to kill any remaining extracellular bacteria.  Cells were 
then fixed and stained for confocal analysis.  The wildtype strain was able to invade, but 
the ΔragB strain did not appear to be able to colonize the TIGKs (Figure 17).  This 
combined with colonization assay CFU counts strongly suggests ragB plays a role in the 





              
 
Figure 17. ragB appears to play a role in invasion of TIGK cell line. 
TIGK cells were (A) unexposed or exposed to (B) W83 and (C) ΔragB strains for 1 hr at 
MOI 10:1.  Cells were washed with PBS and media was replaced with basal media 
containing gentamicin (300 µg/ml) and metronidazole (200 µg/ml) for 1 hr.  Cells were 
then fixed in 4% paraformaldehyde and stained for confocal.  Blue is the DAPI stained 






RagB was expressed in E.coli TOP10 strain and purified under non-denaturing 
conditions as previously stated.  Thioredoxin is a common tag used in the production of 
recombinant proteins with no known inflammatory properties [107]. However, for 
crystallization purposes, it was important to remove the thioredoxin tag, which was 
achieved by EKMax digestion.  Figure 18 represents a 3-D image of the RagB crystal 
structure using Pymol image software. Identification of active sites and other structure 
analysis are currently under investigation.   
 
Figure 18.  RagB crystal structure.  Crystal structure of the 55kDa outer membrane 
protein,  RagB, from P. gingivalis W83.  Stereo ribbon diagram of RagB monomer 





CHAPTER FOUR:  DISCUSSION 
 
P. gingivalis elicits a strong pro-inflammatory response which is thought to 
represent a critical driving force in the progression of periodontal diseases.  This 
inflammation-driven destruction of host cells and tissues enable P. gingivalis to acquire 
essential nutrients [108]. The P. gingivalis armory includes multiple factors that 
manipulate the innate response, including gingipains, LPS, capsule production, fimbrial 
proteins and the rag locus. RagB is a predominant, highly antigenic, environmentally 
regulated, surface-exposed outer membrane protein of P. gingivalis.  Environmental 
stimuli also play a role in RagB expression.  Tobacco smoke, a major risk factor for 
periodontitis, suppresses capsule generation, enhances fimbrial protein expression and 
augments biofilm formation in P. gingivalis [109], which may help to explain the 
increased severity of periodontal diseases observed in smokers.  Tobacco smoke is also a 
potent inducer of RagB expression [109].  RagB expression is also temperature regulated, 
with increased temperature a hallmark of plaque-induced periodontal inflammation [110].   
RagB is homologous to the SusD group of polysaccharide uptake proteins of other 
Bacteroidetes species, including NanU found in Bacteroides fragilis[111].  A Rag 
homologue in Bacteroidetes caccae (OmpW) has been associated with inflammatory 
bowel disease [112].    Subcutaneous inoculation of ragB mutant P. gingivalis into mice 
resulted in attenuated virulence, assessed by soft tissue lesion size and survival [74, 75].  
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Furthermore, the ability of RagB mutants to invade transformed epithelial-like cells is 
curtailed [113].  RagB has also been shown to be associated with more severe forms of 
disease in patients with periodontitis [70].  Despite such data implicating RagB as an 
important immunomodulatory molecule, RagB-innate interactions have not been 
previously examined mechanistically.   
We were unable to induce IL-8 or NFᴋB in the THP-1 cell line with RagB.  A 
recent study concluded THP-1 cells exhibit different inflammatory expression levels than 
primary human monocytes [114].  In this study, both cell types were stimulated with the 
TLR4 agonist, LPS, which induced a minimal IL-8 response in THP-1 cells compared to 
the monocyte expression.  Also, IL-6 and IL-10 were not detected in THP-1 cells in 
response to LPS.  This may help to explain why we were unable to detect a inflammatory 
response to RagB in THP-1 cells.  Consequently, we were unable to induce an IL-8 
response in TLR transfected HEK cells with RagB stimulation.  One possible explanation 
is the cell line is possibly missing an adapter molecule required for TLR/RagB 
interactions.  Therefore, we decided to use a more relevant cell model by using primary 
innate cells for our investigations.   
We show, for the first time, that RagB is a strong TLR agonist.  As has been 
reported for P. gingivalis derived LPS [115], RagB can engage both TLR2 and -4, 
resulting in the induction of multiple pro-inflammatory cytokines including IL-6, IL-8 
and TNF.  This innate activation occurs, unusually, in a STAT4-dependent manner, as 
determined using the pharmaceutical inhibitor, lisofylline, and gene silencing.   
STAT4 is best known as an important transcription factor in non-antigenic 
induction of cytokines in T-cells, type I interferon signaling, and IL-12-mediated 
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development of Th1 cells from naïve CD4
+
 T cells [105, 116, 117].  More recently, 
STAT4 has been shown to be expressed in other immune cells, particularly activated 
monocytic cells [105].  STAT4 has been suggested as a potential therapeutic target for 
various inflammatory diseases, including shock [100, 105, 118, 119].  Whole microbial 
induction of STAT4 expression in innate cells has been established for Mycobacterium 
tuberculosis and Candida albicans [105].  STAT4 has been reported to bind to MyD88, 
the TLR-associated signal transducer, and also to the TNF promoter [120].  STAT4 has 
been shown to result in the induction of IFNγ (interferon gamma) in certain cell types and 
has been shown to be inducible by LPS [121, 122].  IFNγ is a major immune regulator 
involved in many phases of the immune response including TH1 differentiation and 
enhancement of antibody production in response to foreign antigens [123, 124].   Indeed, 
microbial STAT4 activation has been shown to result in the induction of classic NFκB-
regulated cytokines, but not IFNɣ, in conventional dendritic cells [105].  Similarly, we 
could not detect an IFNɣ signal in RagB exposed monocytic cells, despite STAT4 
upregulation (Figure 8).  It has been reported that the activation of STAT4 by IL-12, 
well-defined in T cells, does not occur in innate cells of monocytic lineage [118]. Indeed 
monocytic cell expression of IL-12 receptors is a scientific disagreement.  Grohmann et 
al. show macrophages express the surface receptor IL-12 [125], but Remoli et al. were 
unable to induce IL-12 protein expression [105].   The STAT4 promoter contains an 
NFκB binding site -969/-959 bp upstream from the transcriptional start site that binds 
p65/p50 and p50/p50 dimers [105].  In addition to STAT4-dependence, RagB induction 
of pro-inflammatory cytokines requires NFκB (p65), as determined using both 
pharmaceutical and siRNA approaches. NFκB is the major transcriptional regulator 
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associated with TLR activation.  Thus, RagB activation of the innate response in human 
monocytes exhibits both classical and atypical elements of the TLR signaling pathways. 
Clearly, recombinant RagB may differ from the natural protein, particularly as it 
is not anchored in the cell membrane.  However, the advantage of using recombinant 
technology has been long established.  Recombinant proteins can be readily purified in 
large amounts and be free of accessory proteins (such as RagA).  It is important to note 
RagA and RagB are thought to form a protein-protein complex, raising the question of 
the inflammatory potential to the combined Rag complex.    
With this in mind, we also examined cytokine (IL-6, IL-8 and TNF) production in 
monocytes exposed to WT, ΔragB and complemented P. gingivalis strains.  These data 
support a pro-inflammatory role for RagB in the context of the whole bacterium, similar 
to the recombinant protein.  Bacterial cells were pre-fixed in 1% paraformaldehyde, thus 
controlling for cytokine destruction by secreted gingipains.  Paraformaldehyde has been 
proven to effectively preserve morphology and surface ultra-structure in bacterial cells 
[126]. 
TIGKs were used to determine if RagB plays a role in epithelial cell colonization.    
TIGKs are a recently developed immortalized epithelial cell line used to study oral 
bacteria interactions with host gingival cells [127].  It has previously been suggested that 
the rag locus plays a role in cell invasion based on hybridization arrays comparing 
invasive and non-invasive strains [113].   Using CFU counts and visualization by 
confocal, we showed the ∆ragB mutant strain was unable to colonize TIGK cells.  
However, the complemented mutant was unable to restore colonization capability similar 
to wildtype in TIGKs.   We were able to show the complement strain restore 
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inflammatory responses to wildtype levels, however, the bacteria were fixed in para-
formaldehyde prior to infection.  This may be dueto the large size of the complementing 
vector, or the strain may have become weakened or impaired.  P. gingivalis strains do not 
naturally contain plasmids, thus the plasmid may have impaired intracellular survival.  
An alternative strategy to complementation would be to reinsert the ragB gene back into 
the ∆ragB mutant strain. Established immunomodulatory virulence factors of P. 
gingivalis include LPS, fimbrial proteins (FimA and Mfa1), capsular polysaccharides and 
gingipains [45, 51, 128].  It appears that RagB, which induces multiple pro-inflammatory 
cytokines in a dose-related, TLR-, STAT4- and p65- dependent manner, may now be 
added to this list, at least as ascertained using recombinant protein and rag-specific 
mutants. 
RagB, is assumed to facilitate polysaccharide, or other nutrient transport, along 
with RagA.  The rag locus is thought to facilitate transport through the periplasmic 
spanning protein, TonB.  RagA is a membrane associated protein that forms a pore like 
structure in the outer membrane and RagB is an exposed outer membrane protein.  It has 
been previously proposed that rag may aid in ferrous iron transport [68].  Additionally, a 
study using rag mutants demonstrated a delayed growth rate when compared to wildtype, 
but similar growth rates with digested media suggesting rag may aid in the transport of 
larger peptides [74].  rag locus homologs, the sus system found in Bacteroides sp. are 
involved in sugar uptake [129].  That being said, it is still unclear of the molecules 
transported by the rag locus of P. gingivalis. 
Our initial structural analyses of RagB are suggestive of a disaccharide-binding 
protein (Figure 17).  As P. gingivalis is considered asaccharolytic, however, the 
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physiological relevance of sugar uptake is not immediately transparent, but is likely to be 
important in, for example, capsule generation or other non-ATP generating metabolic 
processes.  Additionally, RagB, as a promoter of inflammation, is likely to contribute to 
the availability of protein, required by P. gingivalis as a carbon source. 
Chronic periodontitis is a major health problem worldwide and is caused by 
persistent stimulation of the innate response to oral pathogens.  Periodontitis is also 
associated with other diseases such as diabetes, rheumatoid arthritis, and cardiovascular 
disease.  Inflammation occurs when immune cells recognize foreign antigens by PPRs.   
P. gingivalis, a causative agent in periodontitis, uses multiple virulence factors to 
establish infection and persist within the host.  Dental biofilms typically develop between 
the tooth and oral epithelium that serve as protective reservoirs for bacteria against the 
innate immune response.  RagB, a major virulence factor of P. gingivalis, is commonly 
associated with severe periodontitis.  This thesis investigates the inflammatory potential 
of RagB and the mechanisms involved.  Studies have shown RagB to be the most 
immune dominant outer membrane antigen of P. gingivalis and have associated it with 
periradicular lesions.  We show RagB elicits a pro-inflammatory response in primary 
monocytes.  This finding may aid in the understanding of the inflammatory response to P. 
gingivalis in periodontal diseases.  With a clear need for better therapeutics and 
preventive strategies for periodontal disease, RagB would serve as a good candidate for 










Studies involving rag mutants and using the Baker bone loss model are currently 
ongoing in the Scott lab [130].  The Baker model will be used to measure ragA and ragB 
contribution to bone loss in context of whole bacterium.  Bacterial burden of P. gingivalis 
strains in the oral cavity and blood will also be examined.  Neutrophil recruitment will 
also be measured in the oral gingival tissues.   
 Tn Seq library of P. gingivalis has been constructed (JH).  The 80,000 colony 
mutant library pool will be used to identify genes as essential in cigarette smoke exposed 
(CSE) media, colonization of epithelial cell line and murine abscess models.   High-
throughput sequencing has been conducted and data analysis is currently underway. 
 
Pharmacological approaches  
Host inflammatory pathways have been used as targets for controlling periodontal 
diseases. Adamowicz et al showed that systemic administration of a GSK3-specific 
inhibitor, SB216763, led to the suppression of P. gingivalis-induced pro-inflammatory 
cytokine production and reduced recruitment of neutrophils, while  abolishing periodontal 
bone loss in mice [131].  Following activation of TLRs in monocytes and PMBCs, 
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GSK3β (glycogen synthase kinase-3) has been shown to be necessary for full stimulation 
of pro-inflammatory cytokines, including IL-6, IL-1β and TNF [132].  We show that 
RagB signals through TLR2 and -4 and induced pro-inflammatory cytokines in a STAT4- 
and p65-dependent manner.   
Therefore, we attempted to use a similar approach of targeting the host 
inflammatory pathway, in vitro.  The STAT4 inhibitor, lisofylline, has been shown to 
reduce diabetes by controlling IL-12 induction of STAT4 in mice [15]. We show 
lisofylline reduces the inflammatory response to RagB in vitro, and thus, may have 
potential in controlling periodontitis in an in vivo model.   By identifying inflammatory 
pathways induced by P. gingivalis, new therapeutic targets can be developed.     
A potential downside of this approach, targeting host inflammatory pathways, is the 
suppression of the innate immune response.  Targeting the host’s immune response is not 
specific to one particular pathogen, thus, can potentially promote increase susceptibility 
to infection by immune suppression.  Alternatively, a more relevant approach would be 
to target antigen specific epitopes of pathogens.  RagB could potentially serve as target 
for P. gingivalis infections based on its location on the outer membrane surface, host 
recognition and specificity to P. gingivalis.   
Implications of a ragB vaccine: 
The potential of ragB as a vaccine candidate has been examined by Zheng et.al 
[76]. A ragB-linked DNA vaccine in mice increased antibody production, reduced lesion 
size and increased resistance to P. gingivalis infection.  DNA vaccines are eukaryotic 
non-replicating expression vectors that can be injected directly into cells, followed by 
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expression of the encoded gene which leads to immune activation against the specific 
antigen being produced [133].  Our data further support targeting RagB as a potential 
therapeutic agent with which to control P. gingivalis-induced inflammatory disease, 
based on surface availability and pro-inflammatory properties. P. gingvalis is a keystone 
pathogen that causes dysbiosis in the oral microbiome, thus, eliminating P. gingivalis 
could allow the microbiome to restore homeostasis.   
However, it must be remembered that there is considerable antigenic variation at 
the rag locus, with at least four non-cross reactive RagB proteins identified [134]. It is 
possible, then, that RagB produced by different P. gingivalis strains may have altered 
inflammatory activities and, thus, exhibit differing virulence potential.  Indeed, the highly 
virulent P. gingivalis lab strains W83 (used herein) and W50 each carry rag1, which has 
been clinically associated with deep periodontal pockets, along with 26% of 168 isolates.  
The less pathogenic strain, ATCC 33277, carries rag4, along with 14% of isolates, which 
cross reacts poorly with W83-specific RagB antibodies [70, 73, 134].  The nucleotide 
sequences of ragA and ragB of 33277 and W83 are 72% and 59% [74].  This may be 
important in the drive to develop RagB-based vaccines for periodontal disease prevention 
[76].  Fortunately, DNA vaccines can be constructed to encode multiple genes on one 






Crystal structure analysis 
The crystal structure of the recombinant RagB is solved and currently being 
analyzed.  The RagB homologs, NanU and SusD, crystal structures have previously been 
published [111, 129]. RagB is surface exposed which provides a potential therapeutic 
target.  The solved structure analysis could potentially be used to identify proteins or 
carbohydrates, active sites able to bind sugars for transport and additional host cell 
receptors capable of binding to RagB.   The solved structure may aid in the development 
of therapeutics towards P. gingivalis associated diseases such as inhibitory peptides to 
block TLR-engagement of RagB or potentially to block attachment to host cells.  Though 
the exact role/s RagB contributes to bacterial survival in vivo has yet to be eluted, RagB 
does appear to play a major role in virulence and could serve as a potential therapeutic 
agent. 
 
Viruelnce models of P. gingivalisIt has been shown that P. gingivalis has the 
ability to invade and colonize epithelial cells.  This allows P. gingivalis to persist and to 
avoid destruction from the host’s immune response.  Previous studies, through the use of 
hybridization arrays, have shown the rag locus to be a potential virulence factor in 
invasion.  It has recently been shown the rag locus to be essential for viability in vitro 
using a mariner transposon system in P. gingivalis strain 33277 [72].  RagB may aid P. 
gingivalis in attachment to the host, modification of host membrane proteins for 
internalization, or survival once internalized within the host cell.  We show ragB mutants 
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were unable to colonize the immortalized oral epithelial cell line, TIGK, using an 
antibiotic protection assay.  The exact role ragB plays in invasion is still unknown and 
additional experiments are required.  One approach would be to use fluorescent labeled P. 
gingivalis to infect TIGKs using confocal microscopy to visualize interactions in real-
time.  An alternative approach would be to perform an invasion assay without the use of 
antibiotics, and count CFUs  to determine if ragB aids in attachment.  RagB may 
potentially be used as a target to block entry and/or attachment to host cells.     
Two previous studies have examined rag mutants using murine soft tissue 
models, which are used to measure inflammatory potential of bacterial strains injected 
dorsal subcutaneously.  They showed rag mutants displayed a reduction in inflammatory 
lesion size, lower CFU recovery in the spleen and increased mice survival rate when 
compared to the wild type strain [74, 75].   These results correlate with our study, 
demonstrating the ragB mutant exhibits a reduction in inflammatory potential compared 
to the parental strain.   
An alternative in vivo model available is the alveolar bone loss model [130].  The 
bone loss model allows for investigations of bacterial induced bone-loss in the oral 
cavity, bacterial burden of the oral cavity, neutrophil recruitment in the gingival tissue 
and systemic inflammatory mediators in the blood.  Additionally, murine dorsal 
subcutaneous chamber model can be utilized to measure inflammatory responses to 
agonists of interest.  Metal chambers are implanted in the backs of mice that allow for an 
environment in which to measure cytokine production, neutrophil infiltration, and 
bacterial growth within the chamber [136].  The rag mutants would be a good candidate 
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for both models.  We would be able to determine the inflammatory potential of rag genes 
in an in vivo model and the role rag plays in the progression of periodontitis.   
 
Summary 
In summary, RagB is a major pro-inflammatory protein of P. gingivalis that is 
recognized by human TLR2 and TLR4.  We have shown RagB to induce pro-
inflammatory cytokines in a p65 and STAT4 dependent manner.  We also show the 
inflammatory potential of ragB in context of the whole bacterium.  The exact role RagB 
contributes in bacterial physiology is still unknown, although, we hope the crystal 
structure yields targets of interest for future investigations.  We also show RagB plays a 
potentially major role in the colonization of TIGK cells which warrants further 
investigation into the mechanisms involved.  We conclude RagB is a major virulence 
factor of P. gingivalis and may serve as a potential therapeutic target for P. gingivalis 
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